Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Goldman Sachs 36th Annual Global Healthcare Conference on Tuesday, June 9, 2015, at 10:40 a.m. PDT (1:40 p.m. EDT/6:40 p.m. BST) from the Terranea Resort in Rancho Palos Verdes, Calif. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.
Eva Stroynowski, +1 781 609 6823